行情

ENDP

ENDP

远藤国际
NASDAQ

实时行情|Nasdaq Last Sale

6.04
-0.14
-2.27%
盘后: 6.04 0 0.00% 17:49 01/17 EST
开盘
6.19
昨收
6.18
最高
6.31
最低
5.92
成交量
715.66万
成交额
--
52周最高
12.49
52周最低
1.970
市值
13.70亿
市盈率(TTM)
-3.2996
分时
5日
1月
3月
1年
5年

分析师评级

14位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ENDP 新闻

  • 420 Investor Alan Brochstein, When Asked About Strength In Cannabis Stocks, Tells Benzinga 'The Organigram report triggered a stampede. I would argue that the way the market shook off "disappointing" results from Aphria the day before was a factor too.'
  • Benzinga.1天前
  • UPDATE: 420 Investor Alan Brochstein Also Tells Benzinga 'There has been extreme pessimism regarding Canadian LPs, and the market views seem to be shifting a bit.'
  • Benzinga.1天前
  • Endo reaches $8.75M opioid settlement with Oklahoma
  • American City Business Journals.3天前
  • Oklahoma sues three opioid distributors over man-made crisis
  • MarketWatch.4天前

更多

所属板块

制药
+0.13%
制药与医学研究
+0.07%

热门股票

名称
价格
涨跌幅

ENDP 简况

Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that includes brand names, such as Lidoderm, OPANA ER, Voltaren Gel, Percocet, Fortesta Gel, Testim, TESTOPEL, Aveed, Supprelin LA and XIAFLEX. Its non-branded U.S. Generic Pharmaceuticals portfolio consists of products, such as tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics and patches. The Company's generics portfolio has a range of dosage forms and delivery systems. The International Pharmaceuticals segment includes various specialty pharmaceutical products for the Canadian, Latin American and world markets.
展开

Webull提供Endo International PLC的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。